Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Pharmacoinformatic approaches to predict substrates and inhibitors of ABCB11/BSEP.

Petra Urach , Gerhard Ecker , Michael Trauner , Peter Chiba
Joint Meeting of the Austrian and German Pharmaceutical Societies
Conference, Poster presentation
..2011 - ..2011

Ligand- and structure-based approaches for targeting drug transporter

Gerhard Ecker
18th European Symposium on Quantitative Structure-Activity Relationships
Conference, Talk or oral contribution
20.9.2010 - 20.9.2010

Experimental data guided ligand docking - a versatile approach for elucidating the molecular basis of drug/transporter interactions

Gerhard Ecker
3rd SFB35 Symposium 2010
Conference, Talk or oral contribution
3.9.2010 - 3.9.2010

Computational drug design - where are we and where to go

Gerhard Ecker
6th PhD-Symposium (Young Scientists Association of the Medical University of Vienna)
Conference, Talk or oral contribution
17.6.2010 - 17.6.2010

Prediction of ADMET – from rules to networks

Gerhard Ecker
3rd European Workshop in Drug Synthesis
Seminar/Workshop, Talk or oral contribution
24.5.2010 - 24.5.2010